Sur cette page
EBS Emergent BioSolutions Inc. Common Stock
NYSE · Biotechnology · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 6, 2026
$6,33
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$4,36Bas 52 semaines
$14,06Haut 52 semaines
Capitalisation Boursière (MRQ)
$325M
P/E (TTM)
-1.8
BPA (TTM)
$-3.46
Revenu (TTM)
$770M
vos badges
Fourchette 52 semaines
$4–$14
Note des analystes
BUY
Objectif de cours
$11
P/E
-1.8
ROE
-40.3%
Marge nette
-23.0%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
EBS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$6.33
Capitalisation Boursière (MRQ)
$325M
P/E (TTM)
-1.8
BPA (TTM)
$-3.46
Revenu (TTM)
$770M
ROE (TTM)
-40.3%
Dette/Capitaux propres (MRQ)
1.7
Fourchette 52 semaines
$4–$14
EBS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$743M2017-12-31 → 2025-12-31
BPA$0.932017-12-31 → 2025-12-31
Flux de trésorerie libre$157M2017-12-31 → 2025-12-31
Marge nette-23.0%2017-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | EBS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -1.8moyenne 5 ans ≈1.9 | ≈1.9 | · | · | |
| P/S (TTM) | 0.4moyenne 5 ans ≈0.5 | ≈0.5 | 25.7 | Sous-évalué | |
| P/B (MRQ) | 1.0moyenne 5 ans ≈0.8 | ≈0.8 | 2.5 | Sous-évalué | |
| EV / EBITDA | 3.6moyenne 5 ans ≈3612.0 | ≈3612.0 | · | · | |
| Cours / FCF (TTM) | 3.8moyenne 5 ans ≈6.0 | ≈6.0 | · | · | |
| Cours / Flux de trésorerie (TTM) | 3.3moyenne 5 ans ≈4.0 | ≈4.0 | · | · | |
| EV / Revenue (VE / Chiffre d'affaires) | 0.9moyenne 5 ans ≈1.2 | ≈1.2 | · | · | |
| EV / FCF (VE / FCF) | 4.4moyenne 5 ans ≈10.6 | ≈10.6 | · | · | |
| Cours / Actif net tangible (MRQ) | 4.1moyenne 5 ans ≈3.4 | ≈3.4 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | EBS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | -8.6%moyenne 5 ans ≈-20.3% | ≈-20.3% | -209.1% | Premier rang | |
| Marge EBITDA (TTM) | 3.7%moyenne 5 ans ≈-11.5% | ≈-11.5% | -209.1% | Premier rang | |
| Marge avant impôts (TTM) | -19.0%moyenne 5 ans ≈-23.0% | ≈-23.0% | -245.7% | Premier rang | |
| Marge nette (TTM) | -23.0%moyenne 5 ans ≈-25.7% | ≈-25.7% | -246.0% | Premier rang | |
| ROA (TTM) | -14.0%moyenne 5 ans ≈-12.8% | ≈-12.8% | -49.3% | Premier rang | |
| ROE (TTM) | -40.3%moyenne 5 ans ≈-47.2% | ≈-47.2% | -64.8% | Premier rang | |
| ROIC | 5.8%moyenne 5 ans ≈-15.4% | ≈-15.4% | -100.1% | Premier rang |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | EBS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Dette / Capitaux propres (MRQ) | 1.7moyenne 5 ans ≈1.5 | ≈1.5 | · | · | |
| Ratio de liquidité (MRQ) | 5.4moyenne 5 ans ≈3.2 | ≈3.2 | 5.1 | En ligne | |
| Quick Ratio (Ratio de liquidité réduite) | 2.2moyenne 5 ans ≈1.4 | ≈1.4 | 2.9 | Faible liquidité | |
| Dette à long terme / Capitaux propres (MRQ) | 1.7moyenne 5 ans ≈1.1 | ≈1.1 | · | · |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | EBS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | -28.8%moyenne 5 ans ≈-18.1% | ≈-18.1% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | -12.7%moyenne 5 ans ≈-13.9% | ≈-13.9% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | -14.0% | · | · | · | |
| EPS CAGR 5Y (TCAC BPA 5 ans) | -30.4% | · | · | · | |
| Net Income CAGR 5Y (TCAC Bénéfice net 5 ans) | -29.7% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | EBS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.5moyenne 5 ans ≈0.5 | ≈0.5 | 0.1 | Premier rang | |
| Inventory Turnover (Rotation des stocks) | 1.0 | · | · | · | |
| Receivables Turnover (Rotation des créances) | 6.2moyenne 5 ans ≈6.1 | ≈6.1 | 2.6 | Premier rang | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$825.4K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
217.1%
Prochain rapport
Oct 27, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 11, 2026 | $0.60 | $0.11 | 440.1% |
| 31 mars 2026 | Mai 13, 2026 | $0.21 | $-0.25 | 183.2% |
| 31 décembre 2025 | $-0.43 | $0.11 | -487.0% | |
| 30 septembre 2025 | $1.06 | $-0.12 | 974.6% | |
| 30 juin 2025 | $0.16 | $-0.49 | 132.3% | |
| 31 mars 2025 | $0.71 | $0.44 | 59.8% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.03 | $8.89 | $12.44 | · | $31.56 | $27.25 | $21.05 | $19.74 | $18.47 | $14.69 | $16.75 | $14.67 | |
| Revenue / Share | $13.10 | $19.69 | $20.49 | $22.31 | $33.14 | $28.91 | $21.11 | $15.22 | $11.14 | $9.91 | $11.06 | $9.83 | |
| Cash Flow / Share | $3.01 | $1.11 | $-4.03 | $-0.68 | $5.94 | $9.96 | $3.59 | $0.81 | $4.14 | $1.08 | $0.94 | $2.45 | |
| Cash / Share | $3.94 | $1.83 | $2.14 | · | $11.23 | $11.70 | $3.25 | $2.19 | $3.61 | $6.69 | $7.94 | $7.44 | |
| EPS (TTM) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | · | 53,200,000 | 54,200,000 | 54,400,000 | · | 53,100,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | · | 56,500,000 | 54,200,000 | 57,300,000 | · | 55,600,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.66 | $10.10 | · | $11.05 | $9.99 | $10.14 | · | $9.40 | $7.30 | $12.67 | · | $13.46 | $18.46 | $23.86 | · | $29.04 | |
| Revenue / Share | $4.54 | $2.76 | · | $4.09 | $2.60 | $3.88 | · | $5.28 | $4.84 | $5.75 | · | $5.22 | $6.66 | $3.29 | · | $4.81 | |
| Cash Flow / Share | · | $-0.60 | · | · | · | $-0.20 | · | · | · | $-1.20 | · | · | · | $-3.67 | · | · | |
| Cash / Share | $2.72 | $3.09 | · | $4.66 | $4.98 | $2.74 | · | $2.77 | $1.32 | $1.50 | · | $1.70 | $1.71 | $8.54 | · | $4.83 | |
| EPS (TTM) | $-3.46 | $-0.19 | · | $1.43 | $2.58 | $-2.58 | · | $-4.05 | $-11.19 | $-10.97 | · | $-15.27 | $-11.94 | $-7.84 | · | $0.40 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $770M | $677M | · | $789M | $852M | $965M | · | $1.13B | $1.10B | $1.19B | · | $1.10B | $1.07B | $977M | · | $1.49B | |
| Net Income TTM | $-177M | $-9M | · | $76M | $140M | $-132M | · | $-209M | $-587M | $-565M | · | $-778M | $-602M | $-393M | · | $33M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -2.4 | -43.7 | · | 6.2 | 2.5 | -1.9 | · | -2.1 | -0.6 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 52.5 | |
| P/S | 0.6 | 0.6 | · | 0.6 | 0.4 | 0.3 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| EV / Revenue | 1.1 | 1.2 | · | 1.1 | 0.9 | 0.8 | · | 0.9 | 1.4 | 1.2 | · | 1.2 | 1.5 | 2.5 | · | 1.3 | |
| Earnings Yield | -41.3% | -2.3% | · | 16.2% | 40.4% | -53.1% | · | -48.5% | -164.1% | -433.6% | · | -449.1% | -162.5% | -75.7% | · | 1.9% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Revenu | $743M | $1.04B | $1.05B | $1.12B | · |
| Marge Brute % | · | · | 30.3% | 34.3% | · |
| Marge d'exploitation % | 13.5% | -10.4% | -69.2% | -15.2% | · |
| Résultat net | $53M | $-191M | $-760M | $-212M | · |
| BPA dilué | $0.93 | $-3.60 | $-14.85 | $-4.22 | · |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 1.1 | 1.4 | 2.0 | · | · |
| Ratio de liquidité | 5.0 | 3.7 | 1.0 | · | · |
| Ratio de liquidité réduite | 2.2 | 1.6 | 0.5 | · | · |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $157M | $36M | $-258M | $-150M | · |
Détenteurs institutionnels (13F) 210 déclarants · $391.0M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
210
Valeur détenue
$391.0M
Nouvelles positions
31
Positions clôturées
24
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 31 (-7 vs T. préc.) | 24 (+1 vs T. préc.) | 71 (+1 vs T. préc.) | 63 (+9 vs T. préc.) | +916K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $43 927 428 | 3 553 999 | 11,23% | Actions |
| BlackRock, Inc. | $39 525 100 | 4 716 599 | 10,11% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $25 782 865 | 3 076 646 | 6,59% | Actions |
| STATE STREET CORP | $24 556 367 | 2 929 238 | 6,28% | Actions |
| AMERICAN CENTURY COMPANIES INC | $23 216 354 | 2 770 448 | 5,94% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $18 426 271 | 2 198 839 | 4,71% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $11 208 910 | 1 337 243 | 2,87% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10 062 629 | 1 200 791 | 2,57% | Actions |
| OAK HILL ADVISORS LP | $9 329 772 | 1 113 338 | 2,39% | Actions |
| MILLENNIUM MANAGEMENT LLC | $8 984 910 | 1 072 185 | 2,30% | Actions |
| AQR CAPITAL MANAGEMENT LLC | $8 724 846 | 1 041 151 | 2,23% | Actions |
| GOLDMAN SACHS GROUP INC | $8 676 828 | 1 035 421 | 2,22% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 626 129 | 1 029 371 | 2,21% | Actions |
| D. E. Shaw & Co., Inc. | $7 542 905 | 900 108 | 1,93% | Actions |
| Russell Investments Group, Ltd. | $7 202 462 | 859 482 | 1,84% | Actions |
| FEDERATED HERMES, INC. | $6 964 828 | 831 125 | 1,78% | Actions |
| PRUDENTIAL FINANCIAL INC | $6 753 400 | 805 895 | 1,73% | Actions |
| Prescott Group Capital Management, L.L.C. | $6 475 821 | 772 771 | 1,66% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $5 725 610 | 683 247 | 1,46% | Actions |
| NORTHERN TRUST CORP | $5 207 944 | 621 473 | 1,33% | Actions |
| Allianz Asset Management GmbH | $4 556 885 | 543 781 | 1,17% | Actions |
| PALISADE CAPITAL MANAGEMENT, LP | $4 316 191 | 515 059 | 1,10% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $4 306 516 | 513 904 | 1,10% | Actions |
| TWO SIGMA INVESTMENTS, LP | $4 091 820 | 488 284 | 1,05% | Actions |
| MORGAN STANLEY | $3 936 225 | 469 715 | 1,01% | Actions |
| Prosight Management, LP | $3 854 398 | 459 952 | 0,99% | Actions |
| Trexquant Investment LP | $3 753 050 | 447 858 | 0,96% | Actions |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3 690 745 | 440 423 | 0,94% | Actions |
| UBS Group AG | $3 067 172 | 366 011 | 0,78% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $2 966 378 | 353 983 | 0,76% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $2 863 614 | 341 720 | 0,73% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $2 757 523 | 329 060 | 0,71% | Actions |
| Values First Advisors, Inc. | $2 526 468 | 301 488 | 0,65% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 420 144 | 288 800 | 0,62% | Option d'achat |
| GLOBEFLEX CAPITAL L P | $2 022 077 | 241 298 | 0,52% | Actions |
| Bank of New York Mellon Corp | $1 840 760 | 219 661 | 0,47% | Actions |
| FMR LLC | $1 794 733 | 214 169 | 0,46% | Actions |
| Brandywine Global Investment Management, LLC | $1 610 632 | 130 310 | 0,41% | Actions |
| DEUTSCHE BANK AG\ | $1 591 513 | 189 918 | 0,41% | Actions |
| Morse Asset Management, Inc | $1 536 339 | 183 334 | 0,39% | Actions |
| WOLVERINE ASSET MANAGEMENT LLC | $1 465 939 | 174 933 | 0,37% | Actions |
| FRANKLIN RESOURCES INC | $1 398 144 | 166 843 | 0,36% | Actions |
| Y-Intercept (Hong Kong) Ltd | $1 390 066 | 165 879 | 0,36% | Actions |
| ARISTEIA CAPITAL, L.L.C. | $1 355 490 | 161 753 | 0,35% | Actions |
| BANK OF AMERICA CORP /DE/ | $1 275 596 | 152 219 | 0,33% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $1 273 476 | 151 966 | 0,33% | Actions |
| Squarepoint Ops LLC | $1 240 374 | 148 016 | 0,32% | Actions |
| CREDIT AGRICOLE S A | $1 225 994 | 146 300 | 0,31% | Actions |
| Invesco Ltd. | $1 224 024 | 146 065 | 0,31% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 028 000 | 122 700 | 0,26% | Actions |
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | 23 août 2010 | · | Dépôt initial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 48 initiés · 12 dirigeants · 11 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | CEO | 4 mars 2019 S | 142 617 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | 8 juin 2026 F | 374 083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | 13 mars 2012 A | 26 614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | 1 juillet 2026 S | 159 098 | 0 | 2 | $-58 960 |
| William Hartzel | SVP, Bioservices | 8 juin 2026 F | 185 558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | 8 juin 2026 F | 202 201 | 0 | 1 | $-306 080 |
| Simon C Lowry | SVP, R&D, CMO | 29 avril 2026 A | 177 914 | 0 | 0 | $0 |
| Jessica Perl | SVP, General Counsel, Corp Sec | 29 avril 2026 A | 165 286 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | 13 novembre 2015 S | 25 182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | 14 mars 2013 F | 28 000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | 15 mars 2011 A | 18 759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | 11 novembre 2010 M | 6 980 | 0 | 0 | $0 |
| Kathryn C Zoon | Administrateur | 30 avril 2026 A | 79 941 | 0 | 2 | $-144 453 |
| Donald W Degolyer | Administrateur | 30 avril 2026 A | 129 721 | 0 | 3 | $-317 617 |
| Sujata Tyagi Dayal | Administrateur | 30 avril 2026 A | 100 563 | 0 | 3 | $-201 130 |
| Neal Franklin Fowler | Administrateur | 30 avril 2026 A | 160 847 | 0 | 0 | $0 |
| Marvin L White | Administrateur | 30 avril 2026 A | 113 839 | 0 | 0 | $0 |
| John D Fowler JR | Administrateur | 30 avril 2026 A | 30 350 | 0 | 0 | $0 |
| Fuad El-Hibri | Administrateur | 3 décembre 2021 J | 206 434 | 0 | 0 | $0 |
| Seamus Mulligan | Administrateur | 19 mars 2019 A | 56 141 | 0 | 0 | $0 |
| John Niederhuber | Administrateur | 18 mai 2016 D | 30 300 | 0 | 0 | $0 |
| Shahzad Malik | Administrateur | 14 juin 2007 A | · | 0 | 0 | $0 |
| Intervac, L.L.C. | Détenteur de 10% | 18 septembre 2012 J | 4 344 250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | Détenteur de 10% | 27 mai 2010 J | 2 265 043 | 0 | 0 | $0 |
| Microscience Investments LTD | Détenteur de 10% | 8 mars 2007 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | · | 30 avril 2026 A | 149 076 | 0 | 0 | $0 |
| Ronald Richard | · | 30 avril 2026 A | 123 761 | 0 | 2 | $-263 101 |
| Keith Katkin | · | 30 avril 2026 A | 96 294 | 0 | 1 | $-128 183 |
| Joseph C Papa | · | 29 avril 2026 A | 493 153 | 0 | 0 | $0 |
| Louis W Sullivan | · | 30 avril 2025 A | 139 098 | 0 | 0 | $0 |
| Jennifer Lynne Fox | · | 11 juillet 2024 A | 186 382 | 0 | 0 | $0 |
| Adam Havey | · | 9 juin 2023 A | 174 398 | 0 | 0 | $0 |
| Robert Kramer | · | 9 juin 2023 A | 506 059 | 0 | 0 | $0 |
| Jerome M Hauer | · | 25 mai 2023 A | 57 508 | 0 | 0 | $0 |
| Katherine Strei | · | 28 février 2023 F | 62 824 | 0 | 0 | $0 |
| Atul Saran | · | 28 février 2023 F | 86 645 | 0 | 0 | $0 |
| George A Joulwan | · | 26 mai 2022 A | 40 244 | 0 | 0 | $0 |
| Karen L. Smith | · | 7 mai 2021 F | 11 888 | 0 | 0 | $0 |
| Sean Kirk | · | 31 mars 2021 F | 17 776 | 0 | 0 | $0 |
| Sue Bailey | · | 4 mars 2021 S | 24 427 | 0 | 0 | $0 |
| Denise Esposito | · | 10 mars 2009 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | · | 4 juin 2008 S | 1 399 764 | 0 | 0 | $0 |
| Joe M Allbaugh | · | 21 mai 2008 A | · | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | · | 28 mars 2008 S | 1 269 390 | 0 | 0 | $0 |
| Mauro Gibellini | · | 4 juin 2007 S | 0 | 0 | 0 | $0 |
| Thomas Zink | · | 17 mai 2007 P | 1 000 | 0 | 0 | $0 |
| Edward Arcuri | · | 8 mai 2007 M | 76 722 | 0 | 0 | $0 |
| Robert Calvin Myers | · | 20 novembre 2006 C | · | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 61 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| EWO · iShares, Inc. | 23,05% | 335 709 SH | 11 septembre 2026 | Quotidien |
| EUFN · iShares Trust | 1,19% | 353 714 SH | 11 septembre 2026 | Quotidien |
| MTRA · Invesco Actively Managed Exchange-T… | 1,14% | 11 292 SH | 1 octobre 2026 | Quotidien |
| MYLD · Cambria ETF Trust | 0,87% | 41 046 NS | 31 juillet 2026 | N-PORT |
| PIZ · Invesco Exchange-Traded Fund Trust … | 0,69% | 33 118 SH | 1 octobre 2026 | Quotidien |
| EZU · iShares, Inc. | 0,57% | 390 787 SH | 11 septembre 2026 | Quotidien |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,40% | 3 381 000 | 1 octobre 2026 | Quotidien |
| DMXF · iShares Trust | 0,40% | 26 552 SH | 11 septembre 2026 | Quotidien |
| IEV · iShares Trust | 0,32% | 37 421 SH | 11 septembre 2026 | Quotidien |
| IVLU · iShares Trust | 0,31% | 102 055 SH | 11 septembre 2026 | Quotidien |
| IXG · iShares Trust | 0,28% | 13 907 SH | 11 septembre 2026 | Quotidien |
| IEUR · iShares Trust | 0,28% | 179 129 SH | 11 septembre 2026 | Quotidien |
| IMTM · iShares Trust | 0,25% | 77 739 SH | 11 septembre 2026 | Quotidien |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,24% | 673 051 SH | 19 août 2026 | Quotidien |
| PABD · iShares Trust | 0,23% | 5 313 SH | 11 septembre 2026 | Quotidien |
| EFG · iShares Trust | 0,20% | 236 854 SH | 11 septembre 2026 | Quotidien |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,20% | 312 634 SH | 19 août 2026 | Quotidien |
| EFA · iShares Trust | 0,20% | 1 097 211 SH | 11 septembre 2026 | Quotidien |
| EFV · iShares Trust | 0,20% | 436 714 SH | 11 septembre 2026 | Quotidien |
| IEFA · iShares Trust | 0,17% | 2 312 794 SH | 11 septembre 2026 | Quotidien |
| IDEV · iShares Trust | 0,15% | 343 523 SH | 11 septembre 2026 | Quotidien |
| ESGD · iShares Trust | 0,14% | 123 676 SH | 11 septembre 2026 | Quotidien |
| ACWX · iShares Trust | 0,12% | 101 401 SH | 11 septembre 2026 | Quotidien |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,11% | 23 661 SH | 1 octobre 2026 | Quotidien |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,11% | 2 737 509 SH | 19 août 2026 | Quotidien |
| VSGX · VANGUARD WORLD FUND | 0,11% | 56 354 SH | 19 août 2026 | Quotidien |
| IXUS · iShares Trust | 0,10% | 431 754 SH | 11 septembre 2026 | Quotidien |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 655 464 SH | 19 août 2026 | Quotidien |
| LABU · Direxion Shares ETF Trust | 0,08% | 57 978 NS | 31 juillet 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,08% | 4 120 164 SH | 19 août 2026 | Quotidien |
| IWC · iShares Trust | 0,07% | 175 885 SH | 11 septembre 2026 | Quotidien |
| TOK · iShares Trust | 0,05% | 841 SH | 11 septembre 2026 | Quotidien |
| URTH · iShares, Inc. | 0,05% | 28 175 SH | 11 septembre 2026 | Quotidien |
| ACWI · iShares Trust | 0,04% | 100 105 SH | 11 septembre 2026 | Quotidien |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 2 979 SH | 1 octobre 2026 | Quotidien |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 242 129 SH | 19 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 45 382 SH | 19 août 2026 | Quotidien |
| DFSV · Dimensional ETF Trust | 0,03% | 304 251 NS | 31 juillet 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 105 903 SH | 1 octobre 2026 | Quotidien |
| PWS · Pacer Funds Trust | 0,02% | 792 NS | 31 juillet 2026 | N-PORT |
| IBB · iShares Trust | 0,02% | 366 188 SH | 11 septembre 2026 | Quotidien |
| DFAT · Dimensional ETF Trust | 0,02% | 374 907 NS | 31 juillet 2026 | N-PORT |
| CRBN · iShares Trust | 0,02% | 1 504 SH | 11 septembre 2026 | Quotidien |
| RSSL · Global X Funds | 0,01% | 24 878 NS | 31 juillet 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1 357 340 SH | 11 septembre 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 299 394 SH | 19 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,01% | 151 590 SH | 19 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,01% | 170 332 NS | 31 juillet 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2 757 NS | 31 juillet 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 140 649 NS | 31 juillet 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5 377 NS | 31 juillet 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2 661 NS | 31 juillet 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 18 981 NS | 31 juillet 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10 026 NS | 31 juillet 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 56 305 SH | 11 septembre 2026 | Quotidien |
| IWV · iShares Trust | 0,00% | 14 557 SH | 4 septembre 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 592 580 SH | 19 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 554 116 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 439 SH | 19 août 2026 | Quotidien |
| IWN · iShares Trust | · | 499 316 SH | 11 septembre 2026 | Quotidien |
| SMLF · iShares Trust | · | 279 031 SH | 11 septembre 2026 | Quotidien |
EBS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 7 analystes
ACHAT
Objectif médian
$11.00
+73,8%
1 14,3%
Achat fort
4 57,1%
Achat
1 14,3%
Conserver
1 14,3%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
2 analystes · 2026-09-28Objectif moyen $11.00 +73,8%
← En dessous de tous les objectifs
Prix actuel $6.33
Bas$10.00
Moyenne$11.00
Haut$12.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | · |
| SRZN | · | · | · | · | · | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
| SCTX | · | · | · | · | · | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 6, 2026